| SINE | Selectively Inhibits Nuclear Export |
| XPO1 | Exportin 1 |
| COVID-19 | Coronavirus Disease 2019 |
| DMD | Duchenne muscular dystrophy |
| DDR | DNA damage response |
| STORM | Selinexor Treatment with Refractory Myeloma |
| BOSTON | Bortezomib, Selinexor, and Dexamethasone in Patients with Multiple Myeloma |
| SADAL | Selinexor in patients with relapsed or refractory diffuse large B-cell lymphom |
| NHL | Non-Hodgkin’s Lymphoma |
| AML | Acute Myeloid Leukemia |
| CLL | Chronic lymphocytic leukemia |
| STS | Soft Tissue Sarcoma |
| NK | Natural Killer |
| HLA-E | Human Leukocyte Antigen E |
| NF-kB | Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B cells |
| IκBα | Inhibitor of NF-kB alpha |
| STAT3 | Signal Transducer and Activator of Transcription 3 |
| NETs | Neutrophil Extracellular Traps |
| ADAR1-p150 | Adenosine Deaminase Acting on RNA 1, p150 isoform |
| LPS | lipopolysaccharide |
| RSV | respiratory syncytial virus |
| HMGB1 | High Mobility Group Box 1 |
| MHV | mouse hepatitis virus |
| FLAG-Ida | Fludarabine, Cytarabine, Granulocyte colony-stimulating factor (G-CSF), and Idarubicin |
| ALT | Alanine Transaminase |
| CRISPR-Cas9 | Clustered Regularly Interspaced Short Palindromic Repeats” and “CRISPR associated protein 9 |
| ASB8 | Ankyrin Repeat and SOCS Box Containing 8 |
| TGFβ-SMAD4 | Transforming Growth Factor Beta-SMAD Family Member 4 Pathway |
| WNT10A | Wnt Family Member 10A |
| DUSP1 | Dual Specificity Phosphatase 1 |
| ETV7 | ETS Variant Transcription Factor 7 |
| ABCC4 | ATP-binding cassette subfamily C member 4 |
| WGCNA | weighted gene co-expression network analysis |
| NFATc1 | Nuclear Factor of Activated T Cells 1 |
| PD | Parkinson’s Disease |
| NLRP3 | NLR Family Pyrin Domain Containing 3 |
| CAVD | calcific aortic valve disease |